Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, March 5, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
Waters new BioAccord System Boosts Innovator and Biosimilar Drug Development
Life Sciences Times
-
March 18, 2021
0
Real Estate
Lendlease and Ivanhoé Cambridge to Develop World-Class Life Science Project in Boston, Retain SGA to Design the Building
Life Sciences Times
-
March 18, 2021
0
Pharma
FSD Pharma Enters into License Agreement to Develop Veterinary Drugs for the Treatment of Dogs and Cats
Life Sciences Times
-
March 17, 2021
0
Life Sciences
Life Sciences Industry Looks to Digital Innovation to Help Navigate the Pandemic and Beyond
Life Sciences Times
-
March 17, 2021
0
Pharma
PerkinElmer Further Expands Capabilities in Biologics Drug Discovery
Life Sciences Times
-
March 17, 2021
0
Venture Capital
IDT Acquires Swift Biosciences
Life Sciences Times
-
March 12, 2021
0
Pharma
ViiV Healthcare presents positive proof-of-concept findings for a novel maturation inhibitor for the treatment of HIV
Life Sciences Times
-
March 9, 2021
0
Public Health
Has COVID Changed Spring Cleaning?
Life Sciences Times
-
March 9, 2021
0
Pharma
ReForm Biologics Announces the Issuance of Chinese Patent for Therapeutic Protein Formulations
Life Sciences Times
-
March 8, 2021
0
Biotech
LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS
Life Sciences Times
-
March 8, 2021
0
1
...
776
777
778
...
805
Page 777 of 805
Most Popular
WHOOP Plans to Add More Than 600 Employees in 2026 as Global Expansion Accelerates
March 4, 2026
Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds
March 4, 2026
CordenPharma Colorado Expands Peptide Development Operations with New Lease at Boulder’s Flatiron Park
March 4, 2026
Affinia Therapeutics Receives FDA Fast Track Designation for AFTX-201 Gene Therapy for BAG3-Associated Dilated Cardiomyopathy
March 4, 2026
Load more
Recent Comments
Recent Comments